Targeting STAT3 Enzyme for Cancer Treatment

被引:0
作者
Arun, Sowmiya [1 ]
Patel, Praveen Kumar [1 ]
Lakshmanan, Kaviarasan [2 ]
Rajangopal, Kalirajan [1 ]
Swaminathan, Gomathi [1 ]
Byran, Gowramma [1 ]
机构
[1] JSS Acad Higher Educ & Res, Dept Pharmaceut Chem, JSS Coll Pharm, Nilgiris 643001, Tamil Nadu, India
[2] Satyabhama Inst Sci & Technol, Sch Pharm, Dept Pharmaceut Chem, Chennai, Tamil Nadu, India
关键词
STAT3; inhibitors; SH-2; domain; proliferation; phosphorylation; hematological malignancies; tyrosine residue; NF-KAPPA-B; SIGNAL TRANSDUCER; TRANSCRIPTION; 3; KEY REGULATOR; EXPRESSION; ACTIVATOR; COMMUNICATION; SUPPRESSOR; APOPTOSIS; REVEALS;
D O I
10.2174/0113895575254012231024062619
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A category of cytoplasmic transcription factors called STATs mediates intracellular signaling, which is frequently generated at receptors on cell surfaces and subsequently sent to the nucleus. STAT3 is a member of a responsible for a variety of human tumor forms, including lymphomas, hematological malignancies, leukemias, multiple myeloma and several solid tumor types. Numerous investigations have demonstrated constitutive STAT3 activation lead to cancer development such as breast, head and neck, lung, colorectal, ovarian, gastric, hepatocellular, and prostate cancers. It's possible to get a hold of the book here. Tumor cells undergo apoptosis when STAT3 activation is suppressed. This review highlights the STAT3 activation and inhibition which can be used for further studies.
引用
收藏
页码:1252 / 1261
页数:10
相关论文
共 67 条
[21]   A Conserved Motif in the Linker Domain of STAT1 Transcription Factor Is Required for Both Recognition and Release from High-Affinity DNA-Binding Sites [J].
Huentelmann, Bettina ;
Staab, Julia ;
Herrmann-Lingen, Christoph ;
Meyer, Thomas .
PLOS ONE, 2014, 9 (05)
[22]   The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer [J].
Hughes, Katherine ;
Watson, Christine J. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)
[23]   Recent advances in apoptosis, mitochondria and drug resistance in cancer cells [J].
Indran, Inthrani R. ;
Tufo, Gregory ;
Pervaiz, Shazib ;
Brenner, Catherine .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2011, 1807 (06) :735-745
[24]   Interleukin-6 induces drug resistance in renal cell carcinoma [J].
Ishibashi, Kei ;
Koguchi, Tomoyuki ;
Matsuoka, Kanako ;
Onagi, Akifumi ;
Tanji, Ryo ;
Takinami-Honda, Ruriko ;
Hoshi, Seiji ;
Onoda, Mitsutaka ;
Kurimura, Yoshimasa ;
Hata, Junya ;
Sato, Yuichi ;
Kataoka, Masao ;
Ogawsa, Soichiro ;
Haga, Nobuhiro ;
Kojima, Yoshiyuki .
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2018, 64 (03) :103-110
[25]  
Jatiani Shashidhar S, 2010, Genes Cancer, V1, P979, DOI 10.1177/1947601910397187
[26]   Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad [J].
Kang, Ju-Hee ;
Jang, Yeong-Su ;
Lee, Ha Jung ;
Lee, Chang-Yong ;
Shin, Dong Yun ;
Oh, Seung Hyun .
LABORATORY ANIMAL RESEARCH, 2019, 35 (01)
[27]  
Kojima Hirotada, 2013, JAKSTAT, V2, pe25763, DOI 10.4161/jkst.25763
[28]   Integration of genome-wide of Stat3 binding and epigenetic modification mapping with transcriptome reveals novel Stat3 target genes in glioma cells [J].
Kruczyk, Marcin ;
Przanowski, Piotr ;
Dabrowski, Michal ;
Swiatek-Machado, Karolina ;
Mieczkowski, Jakub ;
Wallerman, Ola ;
Ronowicz, Anna ;
Piotrowski, Arkadiusz ;
Wadelius, Claes ;
Kaminska, Bozena ;
Komorowski, Jan .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2014, 1839 (11) :1341-1350
[29]   STAT3: A Target to Enhance Antitumor Immune Response [J].
Lee, Heehyoung ;
Pal, Sumanta Kumar ;
Reckamp, Karen ;
Figlin, Robert A. ;
Yu, Hua .
CANCER IMMUNOLOGY AND IMMUNOTHERAPY, 2011, 344 :41-59
[30]   The stat3/socs3a Pathway Is a Key Regulator of Hair Cell Regeneration in Zebrafish stat3/socs3a Pathway: Regulator of Hair Cell Regeneration [J].
Liang, Jin ;
Wang, Dongmei ;
Renaud, Gabriel ;
Wolfsberg, Tyra G. ;
Wilson, Alexander F. ;
Burgess, Shawn M. .
JOURNAL OF NEUROSCIENCE, 2012, 32 (31) :10662-10673